비스포스포네이트로 인한 하악 및 상악골에 발생한 골괴사에 대한 임상적 연구
CLINICAL STUDY OF BISPHOSPHONATE-INDUCED OSTEONECROSIS OF MANDIBULAR AND MAXILLARY BONE
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Bisphosphonates are compounds widely used in the treatment of various metabolic and malignant bone disease. Recently, an association between bisphosphonate use and a rare dental condition termed 'osteonecrosis of the jaw(ONJ)' has been reported. Bisphosphonate-related osteonecrosis of the jaw(BRONJ) is rare, but serious, side effect of bisphosphonate therapy in affected patients. It is characterized by poor wound healing and spontaneous intra-oral soft tissue break down, which lead to exposure of necrotic maxillary and mandibular bone. We reviewed 11 patients of BRONJ visited Ajou University Hospital Dental clinic from May 2007 to November 2008. The management of the patients included cessation of bisphosphonate therapy and various surgical restorative procedures and conservative care there after. Aggressive debridement is contraindicated. A new complication of bisphosphonate therapy administration, osteonecrosis of jaws, seems to be developing. The improved results after cessation of the medication should make clinicians reconsider the merits of the rampant use of bisphosphonates, while further investigation is needed to completely elucidate this complication.
Abstract
Bisphosphonates are compounds widely used in the treatment of various metabolic and malignant bone disease. Recently, an association between bisphosphonate use and a rare dental condition termed 'osteonecrosis of the jaw(ONJ)' has been reported. Bisphosphonate-related osteonecrosis of the jaw(BRONJ) is rare, but serious, side effect of bisphosphonate therapy in affected patients. It is characterized by poor wound healing and spontaneous intra-oral soft tissue break down, which lead to exposure of necrotic maxillary and mandibular bone. We reviewed 11 patients of BRONJ visited Ajou University Hospital Dental clinic from May 2007 to November 2008. The management of the patients included cessation of bisphosphonate therapy and various surgical restorative procedures and conservative care there after. Aggressive debridement is contraindicated. A new complication of bisphosphonate therapy administration, osteonecrosis of jaws, seems to be developing. The improved results after cessation of the medication should make clinicians reconsider the merits of the rampant use of bisphosphonates, while further investigation is needed to completely elucidate this complication.
참고문헌 (29)
- Marx RE, "Pamidronate (AREDIA) and zoledronate(ZOMETA) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1118 (2003)
- Saad F, "Clinical benefits and considerations of bisphosphonate treatment in metastatic bone disease", Semin Oncol, 34(4), pp.17~23 (2007)
- Owens G, "An integrated approach: bisphosphonate management for the treatment of osteoporosis", Am J Manag Care, 13(11), pp.290~308 (2007)
- Diel IJ, "Adverse effects of bisphophonates: current issues", J Support Oncol, 5, pp.475~482 (2007)
- Migliorati CA, "Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper", J AM Dent Assoc, 136, pp.1658~1668 (2005)
- Woo SB, "Systematic review:bisphosphonate and osteonecrosis of the jaws", Ann Intern Med, 144, pp.753~761 (2006)
- Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65, pp.369~376 (2007)
- Khosla S, "Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research", J Bone Miner Res, 22, pp.1479~1491 (2007)
- Berenson JR, "American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma", Clin Oncol, 20, pp.3719~3736 (2002)
- Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates : a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
- Marx RE, "Bisphosphonate-induced exposed bone (osteonecrosis", osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment, 2005, pp.63, 1567~1575
- Papapoulos SE, "Bisphosphonate actions: physical chemistry revisited", Bone, 38, pp.613~616 (2006)
- Zavras AI, "Bisphosphonates are associated with increased risk for jaw surgery in medical claims data: is it osteonecrosis?", J Oral Maxillofac Surg, 64, pp.917~923 (2006)
- Rogers MJ, "Cellular and molecular mechanism of action of bisphosphonates", Cancer, 88, pp.2961~2978 (2000)
- Yarom N, "Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome", Osteoporos Int, 18, pp.1363~1370 (2007)
- Marx RE, "Oral & intravenous bisphosphonate-induced osteonecrosis of the jaws: History, etiology, prevention, and treatment" (2007), Quintessence Publishing
- Lam DK, "A review of bisphos phonate - associated osteonecrosis of the jaws and its management", J Can Dent Assoc, 73, pp.417~422 (2007)
- Reid IR, "Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?", Bone, 41, pp.318~320 (2007)
- Phal PM, "Imaging findings of bisphoshonate- associated osteonecrosis of the jaws", Am J Neuroradiol, 28, pp.1139~1145 (2007)
- 권용대, "Bisphosphonate, 구강악안면외과 영역의 새로운 위험 요소인가?", 대한악안면성형재건외과학회지, 29(5), pp.456~462 (2007), 대한악안면성형재건외과학회
- Wilkinson G, "Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis", J Natl Cancer Inst, 99, pp.1016~1024 (2007)
- Mavrokokki A, "Nature and frequency of bisphosphonate -associated osteonecrosis of the jaws in Australia", J Oral Maxillofac Surg, 65, pp.415~423 (2007)
- Drexler HC, "Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells", FASEB J, 20, pp.4319~4323 (2000)
- Durie BG, "Osteonecrosis of the jaw and bisphosphonate", Med, 353, pp.99~102 (2005)
- Guerrero ME, "State-of-the-art on cone beam CT imaging for preoperative planning of implant placement", Clin Oral Investig, 10, pp.1~7 (2006)
- Schulze D, "Diagnostic criteria for the detection of mandibular osteomyelitis using cone-beam computed tomography", Dentomaxillofac Radiol, 35, pp.232~235 (2006)
- Wutzl A, "Osteonecrosis of the jaws and bisphosphonate treatmentin cancer patients", Wien Klin Wochenschr, 118, pp.473~478 (2006)
- Rizzoli R, "Review: Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis", Bone, 42, pp.841~847 (2008)
- Chhoeu AH, "A case series of hyperbaric oxygen treatment for non-radiation induced osteonecrosis of the jaw", J Oral MaxillofacSurg, 64, pp.80~81 (2006)